Grant

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

CountryUnited States
Deadline2027-02-03 (73 days left)
Published2024-12-05
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity PAR-25-025. CFDA: 93.838, 93.233, 93.837, 93.839

The buyer, the value, the full description and the link to the official notice are available with a free account.